S-Methyl glutathione

Tripeptide DerivativeRx: UnknownCompound: Research

Also known as: GSMe, S-Me-GSH, S-Methylglutathione, S‑Methyl‑GSH, S‑Methylglutathione, γ-L-Glutamyl-S-methyl-L-cysteinylglycine

Educational Only — Not medical advice. Consult a qualified clinician before using any peptide.

Source S-Methyl glutathione at Peptiology

Save 10% with code PEPTI-BOSSRABBIT-10

Shop Now & Save 10% →

Tapping Shop Now & Save 10% copies your 10% off code PEPTI-BOSSRABBIT-10 to your clipboard. Paste it at the Peptiology checkout to claim the discount.

Summary

S-Methylglutathione is a methylated analogue of the endogenous tripeptide glutathione (γ‑glutamyl‑cysteinyl‑glycine), where the cysteine thiol is methylated. It occurs as a metabolic product and is used primarily as a biochemical marker rather than a therapeutic agent.

Mechanism of Action

S-Methyl glutathione is a methylated derivative of glutathione (γ-L-glutamyl-L-cysteinyl-glycine) in which the thiol group of the cysteine residue is methylated. It acts as a stable glutathione analog, potentially modulating redox homeostasis, supporting antioxidant defense, and serving as a substrate or inhibitor in glutathione-dependent enzymatic pathways including glutathione S-transferases.

Routes of Administration

Research Use Only (in Vitro / Ex Vivo)

Goals & Uses

  • Glutathione metabolism tracerMetabolic ResearchModerate
  • Glutathione S-transferase substrate/inhibitor researchEnzymologyModerate
  • Antioxidant defense modulationBiochemical ResearchLow

Contraindications

  • Human therapeutic useRegulatory/safetyHigh

Adverse Effects

  • Unknown systemic effectsGeneralUnknown

Drug Interactions

No drug interactions recorded yet.

Population Constraints

  • All clinical populationsRegulatory / SafetyAbsolute

Regulatory Status

  • European UnionUnapprovedNot approved by EMA.
  • United StatesUnapprovedNot approved by FDA; available only as a research chemical.
  • United KingdomUnapprovedNot approved by MHRA.

No approved therapeutic indication in any major jurisdiction. Used as a research/reference compound. Not listed as an approved drug by FDA, EMA, or MHRA.

Evidence & Sources

No sources recorded yet.

Frequently Asked Questions

What is S-Methyl glutathione?

S-Methylglutathione is a methylated analogue of the endogenous tripeptide glutathione (γ‑glutamyl‑cysteinyl‑glycine), where the cysteine thiol is methylated. It occurs as a metabolic product and is used primarily as a biochemical marker rather than a therapeutic agent.

What is S-Methyl glutathione used for?

S-Methyl glutathione is educationally associated with: Glutathione metabolism tracer, Glutathione S-transferase substrate/inhibitor research, Antioxidant defense modulation. Educational only — not medical advice.

How is S-Methyl glutathione administered?

Recorded routes of administration: Research Use Only (in Vitro / Ex Vivo).

What are the potential side effects of S-Methyl glutathione?

Reported adverse effects include: Unknown systemic effects. This list is not exhaustive — consult a qualified clinician.

Who should avoid S-Methyl glutathione?

Recorded contraindications: Human therapeutic use. Consult a qualified clinician before use.